biomodal
biomodal is a biotech company that develops DNA sequencing tools to analyze genetic and epigenetic data from a single sample, with $155M in funding from investors including Sequoia Capital and Google Ventures. The company's technology aims to simplify complex biological analysis for research in cancer, neurodegenerative diseases, and aging.
The growth story
biomodal grew from 31 to 91 employees between 2021 and 2026, raising $155M along the way, most recently a Series D in November 2021.
About
biomodal sells lab tools that extract both genetic and epigenetic information from small DNA samples without requiring harsh chemical treatments. Researchers use these to study diseases like cancer and Alzheimer's with less sample preparation than traditional methods.
The company was recognized in The Sunday Times 100 Tech 2026 list for fast growth. It raised $155M in a 2021 Series D round led by prominent investors including Sequoia and GV, suggesting strong backing for its sequencing approach.
Founders and leadership
Research makes up the largest department with 30 staff. The company has a median tenure of 2 years, typical for a venture-backed biotech firm.
The biomodal org chart
Peter Fromen (Chief Executive Officer) leads 37 mapped leaders with 10 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 37 (-21% YoY), Sales 9 (+29% YoY), Engineering 7 (-30% YoY), Business Development 7 (-22% YoY), Information Technology 5 (-17% YoY), Human Resources 4 (-20% YoY).
Talent flow
Nearly 20% of hires come from sequencing leader Illumina, with others from academic institutions like Cambridge University and Karolinska Institutet. Alumni frequently move to other biotech startups, with 8 founding their own companies.
Most common previous employers of biomodal staff: Illumina (15), University of Cambridge (7), Thermo Fisher Scientific (6), Wellcome Sanger Institute (5), PacBio (5), Karolinska Institutet (5). Former biomodal employees most often moved to Tagomics (6), Illumina (5), AstraZeneca (4), GSK (2), Syndex Bio (2), Relation (2).
Alumni worth knowing
The biomodal mafia
Former employees have founded at least 8 companies, including Syndex Bio (28 staff) and OtoImmune (7 staff), showing biomodal's role as a biotech talent hub.
8Geoff Smith, was CEO until 2017Jason Mellad, was CEO until 2019Hayden Jeffreys, was COO until 2018Andreas Claas, was Senior Development Scientist / Senior Project Manager, R&D until 2016Fedja Bobanović, was Chief Executive Officer until 2015Joanna Holbrook, was Chief Scientific Officer until 2023
Chris Anderson, was Cambridge Epigenetic - Office Manager until 2021
Sidong Liu, was Senior Advanced Research Scientist until 2019Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at biomodal: Molecular Biology (42), Biochemistry (33), Research Skills (31), Life Sciences (28), Biotechnology (27), Genetics (26), Communication (26), Genomics (25).
Where the team actually sits
biomodal people are concentrated in England, United Kingdom (41), Greater Cambridge Area (14), United Kingdom (10), California, United States (3).
Search footprint
biomodal attracts about 13,370 organic search visits a month, traffic worth roughly $12K a month if bought through ads. It gained 933 ranking keywords and lost 568 in the last period.
What employees say
- Compensation
- 3.60 / 5
- Career opportunities
- 3.30 / 5
- Senior management
- 3.20 / 5
- Work-life balance
- 3.80 / 5
Frequently asked
biomodal has 91 employees as of September 2026.
biomodal has raised $155M in total, most recently a Series D round in November 2021.
biomodal was founded in 2012 by Bobby Yerramilli-Rao.
Peter Fromen (Chief Executive Officer) sits at the top of biomodal's reporting structure, with 10 direct reports.
The most common previous employers of current biomodal staff are Illumina (15 people), University of Cambridge (7 people), Thermo Fisher Scientific (6 people).
Former biomodal employees most often move to Tagomics (6), Illumina (5), AstraZeneca (4).
At least 8 companies have a founder who previously worked at biomodal, including Syndex Bio, OtoImmune, Wisdom Bioscience.
biomodal attracts about 13,370 organic search visits a month, worth roughly $12K a month in equivalent ad spend.
The most common skills among biomodal staff are Molecular Biology, Biochemistry, Research Skills, Life Sciences, Biotechnology.
biomodal staff are concentrated in England, United Kingdom (41), Greater Cambridge Area (14), United Kingdom (10).
biomodal has about 37 people in Research, down 21% over the past year, as of September 2026.
biomodal has about 9 people in Sales, up 29% over the past year, as of September 2026.
Computed from 85 current and 159 former biomodal profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.